Experience with Björk-Shiley valvular replacement. A preliminary report.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001021:Aortic Valve / Q000601:surgery; D002302:Cardiac Output; D005500:Follow-Up Studies; D006242:Haptoglobins / Q000032:analysis; D006350:Heart Valve Prosthesis / Q000009:adverse effects / Q000401:mortality; D006461:Hemolysis; D006801:Humans; D017053:Infection Control; D008943:Mitral Valve / Q000601:surgery; D011183:Postoperative Complications; D012422:Rupture, Spontaneous; D013923:Thromboembolism / Q000209:etiology; D013997:Time Factors; D014261:Tricuspid Valve / Q000601:surgery; D014690:Venous Pressure
D000900:Anti-Bacterial Agents; D006242:Haptoglobins